Skip to content

Doxapram as an Additive to Propofol Sedation in Sedation for ERCP

Doxapram as an Additive to Propofol Sedation in Sedation for Endoscopic Retrograde Cholangiopancreatography

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02171910
Enrollment
50
Registered
2014-06-24
Start date
2016-10-31
Completion date
2016-12-31
Last updated
2016-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia, Sedation

Keywords

Cholangiopancreatography, Endoscopic Retrograde, Sedation

Brief summary

Sedation is needed in order to complete endoscopic retrograde cholangiopancreatography (ERCP) to alleviate discomfort and pain during the procedure. This is usually achieved with use of opioids and/or sedative agents such as benzodiazepines or propofol. Traditionally benzodiazepines have been used but nowadays propofol is becoming the drug of choice for sedation during ERCP. The problem with propofol sedation is the fact that it may case cardiorespiratory depression and there is no antidote for this like there is for benzodiazepines. Cardiovascular depression can usually be easily counteracted with drugs that are used to raise blood pressure or heart rate during general anesthesia but respiratory depression remains a problem. The aim of this study is to try to counteract the respiratory depression caused by propofol sedation using an old respiratory stimulant doxapram as opposed to placebo using a double blind randomized protocol. The investigators hypothesis is that boluses and an infusion of doxapram will alleviate the respiratory depression caused by propofol sedation.

Interventions

DRUGPlacebo

An injection and infusion of normal saline (NaCl 0.9%) as a placebo comparator to doxapram

Sponsors

Helsinki University Central Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* \< 75 year of age * Having ERCP * Agrees to take part in the study

Exclusion criteria

* \>75 years of age * allergy to propofol or doxapram * epilepsy * Chronic Obstructive Pulmonary disease (COPD) * Coronary artery disease (symptomatic) * alcoholism * declines to take part in the study

Design outcomes

Primary

MeasureTime frameDescription
Change in arterial oxygenationvalues recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedure, on arrival at the recovery room and at 5 min, 10 min, and after that at 10 min intervals until discharge to wardHypoxemia, oxygen saturation by pulse oximetry (SpO2 \<90%), considered as a significant change

Secondary

MeasureTime frameDescription
change in systolic arterial pressurevalues recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedure, on arrival at the recovery room and at 5 min, 10 min, and after that at 10 min intervals until discharge to wardA drop of systolic arterial pressure to \<90 mmHg is considered significant
Pulse (heartbeats/minute)values recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedure, on arrival at the recovery room and at 5 min, 10 min, and after that at 10 min intervals until discharge to ward
breathing rate (breaths/minute)values recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedure

Other

MeasureTime frameDescription
Sedation scalesvalues recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedureModified observer's assessment of Alertness/sedation (MOAA(S) and Bispectral Index (BiS)
End-tidal carbon dioxide (CO2)values recorded before the procedure, during the procedure at 5 min intervals and at the end of the procedureA sampling catheter is placed in the nostril
Patient satisfactionin the recovery room before discharge to wardThe patient is asked to rate satisfaction to the given sedation on a seven step scale ranging from extremely dissatisfied to extremely satisfied
operating physician satisfactionat the end of the procedureThe operating physician is given a questionnaire and rates the following on a 4 step scale each: ease of applying the endoscope, patient co-operation, gagging/vomiting, coughing, belching, distracting movement of the patient. Also difficulty of the procedure is rated on a three step scale

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026